Every Form 4 that Mobix Labs, Inc Warrants (MOBXW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MOBXW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MOBXW filings page.
Mobix Labs, Inc. Chief Executive Officer and director Philip Sansone reported selling 2,614 shares of Class A common stock on October 8, 2026, at a weighted average price of $1.1223 per share; the reported prices ranged from $1.1202 to $1.125 per share. The shares were sold solely to cover tax liability associated with restricted stock units that vested on October 1, 2026, under Sansone’s irrevocable election for “sell to cover” transactions; the sales do not represent discretionary trades. After the sale, he directly held 163,516 shares.
MOBIX LABS, INC (symbol: MOBX) is the issuer of record for a Form 4 filing submitted to the SEC. LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
MOBIX LABS, INC (MOBX) reported that director Michael J. Long received two equity compensation awards in the form of Restricted Stock Units for its Class A Common Stock on September 14, 2026. The awards cover 12,255 RSUs vesting on September 30, 2026 and 19,101 RSUs vesting on October 1, 2026, each granted at no cash cost to him. These awards are classified as direct beneficial ownership, and no Rule 10b5-1 trading plan is reported in connection with these transactions.
MOBIX LABS, INC (MOBX) director Kurt Busch reported receiving two equity awards in the form of Restricted Stock Units and also reported existing stock option holdings. On September 14, 2026 he was granted 12,255 RSUs that vest on September 30, 2026 and 19,101 RSUs that vest on October 1, 2026. He also holds fully vested options to purchase Class A Common Stock, covering 2,000 shares at an exercise price of $41.80 per share expiring August 10, 2030, and 13,341 shares at an exercise price of $68.40 per share expiring April 4, 2032.
MOBIX LABS, INC (symbol: MOBX) is the issuer of record for a Form 4 filing submitted to the SEC. Peterson James J reported acquisition or exercise transactions in this Form 4 filing.
MOBIX LABS, INC (MOBX) reported that director James J. Peterson received two equity awards of its Class A Common Stock on September 14, 2026. He was granted 12,255 Restricted Stock Units vesting on September 30, 2026 and 19,101 Restricted Stock Units vesting on October 1, 2026. The filing also lists fully vested stock options giving him the right to buy 2,000 shares at $41.80 per share until August 10, 2030 and 13,341 shares at $68.40 per share until April 4, 2032. The Rule 10b5-1 box is unchecked, so no trading plan is reported for these awards.
MOBIX LABS, INC (symbol: MOBX) is the issuer of record for a Form 4 filing submitted to the SEC. Goerner Frederick C reported acquisition or exercise transactions in this Form 4 filing.
MOBIX LABS, INC (MOBX) director Frederick C. Goerner reported awards of Class A common stock on September 14, 2026. He received 12,255 restricted stock units vesting on September 30, 2026 and 19,101 restricted stock units vesting on October 1, 2026, plus reported fully vested options for additional Class A shares. No purchases or sales of common stock are disclosed, and no Rule 10b5-1 trading plan is reported.
MOBIX LABS, INC (symbol: MOBX) is the issuer of record for a Form 4 filing submitted to the SEC. ALDRICH DAVID J reported acquisition or exercise transactions in this Form 4 filing.
MOBIX LABS, INC (MOBX) director David J. Aldrich reported equity awards consisting of 12,255 and 19,101 Restricted Stock Units granted on September 14, 2026, which vest on September 30, 2026 and October 1, 2026, respectively. He also holds fully vested options to buy 2,000 shares at $41.80 per share expiring August 10, 2030 and 13,341 shares at $68.40 per share expiring April 4, 2032. The filing indicates these transactions were not made under a Rule 10b5-1 trading plan.
MOBIX LABS, INC (symbol: MOBX) is the issuer of record for a Form 4 filing submitted to the SEC. Carpou Bill reported acquisition or exercise transactions in this Form 4 filing.
MOBIX LABS, INC (MOBX) reported that director Bill Carpou received equity awards on September 14, 2026. He was granted Restricted Stock Units covering 12,255 shares of Class A common stock that vest on September 30, 2026 and 19,101 shares that vest on October 1, 2026. He also holds fully vested stock options to buy Class A common stock, including rights over 2,000 shares at $41.80 per share expiring August 10, 2030 and 13,341 shares at $68.40 per share expiring April 4, 2032. No sales were reported and no Rule 10b5-1 trading plan is reported.
MOBIX LABS, INC (MOBX) director and executive officer Keyvan Samini reported a conversion of 12,500 shares of Class B Common Stock held indirectly through the KSSF Trust into 12,500 shares of Class A Common Stock on a one-for-one basis, with no consideration paid, pursuant to the company’s certificate of incorporation. After the conversion, the KSSF Trust held 29,614 Class A shares, and Mr. Samini also reported 155,053 Class A shares held directly, plus additional indirect Class A holdings through other trusts. He further reported fully vested options to acquire 32,353 Class A shares at $1.70 per share, expiring on August 10, 2030. For trust-held shares, he disclaims beneficial ownership except to the extent of his pecuniary interest.
MOBIX LABS, INC (symbol: MOBX) is the issuer of record for a Form 4 filing submitted to the SEC.
MOBIX LABS, INC (MOBX) director Frederick C. Goerner reported a conversion of 21,739 shares of Class B Common Stock into 21,739 shares of Class A Common Stock on August 21, 2026. The conversion was on a one-for-one basis pursuant to the company’s Certificate of Incorporation, and no consideration was paid.
Following the conversion, Goerner directly holds 207,456 shares of Class A Common Stock. He also holds fully vested options to acquire additional Class A shares, including options over 2,000 shares at $41.80 per share expiring August 10, 2030 and options over 13,341 shares at $68.40 per share expiring April 4, 2032.
Mobix Labs, Inc. director and Chief Executive Officer Philip Sansone reported selling 9,301 shares of Class A common stock on July 16, 2026 at a weighted average price of $1.8669 per share, leaving 166,130 shares held directly. The sale was made under an irrevocable “sell to cover” election solely to satisfy tax withholding from restricted stock units vesting that day and is described as non-discretionary.
MOBIX LABS, INC director Bill Carpou reported an equity compensation grant and his outstanding option holdings. He received 13,660 shares of Class A Common Stock on June 30, 2026 at a price of $0.00 per share, classified as a grant or award, bringing his direct holdings to 67,282 shares after the transaction. Footnotes state these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026, meaning they became fully earned one day after grant.
The filing also lists two fully vested stock option positions. One option covers 13,341 underlying Class A Common shares at an exercise price of $68.40 per share, expiring on April 4, 2032. Another option covers 2,000 underlying shares at an exercise price of $41.80, expiring on August 10, 2030. No open-market buys or sells were reported; the activity reflects compensation and existing derivative holdings.
MOBIX LABS, INC director and 10% owner James J. Peterson received an equity award in the form of Class A Common Stock. He acquired 13,660 shares of Class A Common Stock on a grant or award basis at a stated price of $0.00 per share, tied to Restricted Stock Units granted on June 30, 2026 that vested on July 1, 2026.
Following this award, he directly holds 339,122 shares of Class A Common Stock. He also has derivative positions linked to Class A shares: 144,927 underlying shares through Class B Common Stock that is convertible into Class A, plus fully vested options covering 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and 2,000 shares at $41.80 per share expiring on August 10, 2030.
LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
MOBIX LABS, INC director Michael J. Long received an equity award in the form of restricted stock units. The Form 4 shows a grant of 13,660 shares of Class A common stock at no cash cost to him, increasing his directly held position to 138,592 shares.
The footnote explains these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026, indicating this was a compensation-related award rather than an open-market purchase or sale.
Goerner Frederick C reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs director Frederick C. Goerner received an equity award of 13,660 shares of Class A Common Stock on June 30, 2026, at a price of $0.0000 per share. These shares relate to Restricted Stock Units granted on June 30, 2026 that vested on July 1, 2026. Following this grant, he directly holds 185,717 shares of Class A Common Stock. He also holds Class B Common Stock convertible into 21,739 Class A shares at his option, plus fully vested options to buy 13,341 Class A shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
Mobix Labs director Kurt Busch reported a new equity grant. He received 13,660 shares of Class A Common Stock as a grant or award at a price of $0.00 per share, increasing his direct holdings to 74,621 shares. Footnotes state these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026.
He also holds fully vested options to buy 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and options to buy 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS director David J. Aldrich reported a stock award of 13,660 Class A common shares as compensation. These shares were granted on June 30, 2026 at no cost and arose from Restricted Stock Units that vested on July 1, 2026.
After this grant, Aldrich directly owned 66,353 shares of Class A common stock. He also held fully vested options over 13,341 shares with a $68.40 exercise price expiring April 4, 2032, and options over 2,000 shares with a $41.80 exercise price expiring August 10, 2030.
MOBIX Labs President, CFO and Director Keyvan Samini reported selling Class A Common Stock in open-market transactions. On June 12, 2026, he sold 112,110 shares at a weighted average price of $1.9807 per share. On June 11, 2026, he sold an additional 3 shares at a weighted average price of $2.1367 per share.
After these sales, Samini directly holds 155,053 Class A shares. The filing also shows indirect holdings in several trusts and remaining equity exposure through fully vested options to buy 32,353 Class A shares at $1.70 per share and Class B shares convertible into 12,500 Class A shares.
LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs, Inc. director Michael J. Long reported equity awards in the company’s Class A common stock. He received 14,805 shares on February 25, 2026 and an additional 5,000 shares on March 30, 2026, both recorded as grants or awards at a price of $0.00 per share.
After these transactions, Long directly owned 124,932 shares of Class A common stock. A footnote explains that an earlier grant of Restricted Stock Units was made on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership was adjusted for rounding following a 1-for-10 reverse stock split effective April 6, 2026.
Mobix Labs director Kurt Busch reported new equity awards in Mobix Labs, Inc. Class A Common Stock. He received 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026 as grant or award acquisitions at no stated purchase price.
After these awards, Busch directly owns 60,961 Class A shares. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030. Reported holdings reflect a 1-for-10 reverse stock split on April 6, 2026.
MOBIX Labs director and 10% owner James J. Peterson reported stock awards and updated holdings in the company’s shares. He received Class A Common Stock awards of 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026, both at $0.00 per share as grants.
Following the latest award, he directly holds 325,462 shares of Class A Common Stock. Footnotes state these Restricted Stock Units were granted on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership figures were adjusted for a 1-for-10 reverse stock split effective April 6, 2026. He also holds Class B Common Stock convertible into 144,927 Class A shares at the holder’s option, plus fully vested options over 13,341 Class A shares at an exercise price of $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS, INC director Frederick C. Goerner reported stock-based compensation awards rather than open‑market trades. He received grants of 14,805 and 5,000 shares of Class A Common Stock at a price of $0.00 per share, described as restricted stock units that were granted on February 25, 2026 and vested on April 1, 2026.
After these awards, he directly owns 172,057 shares of Class A Common Stock. He also holds Class B Common Stock convertible into 21,739 Class A shares at an exercise price of $0.00, plus fully vested options covering 13,341 shares at $68.40 per share and 2,000 shares at $41.80 per share.
ALDRICH DAVID J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs director David J. Aldrich reported equity awards in MOBX stock. He received grants of 14,805 shares of Class A Common Stock on February 25, 2026 and 5,000 shares on March 30, 2026, both at a stated price of $0.00 per share, reflecting compensation rather than open‑market purchases. Following these awards, he directly holds 52,693 Class A shares. Footnotes state the February 25, 2026 award consisted of Restricted Stock Units that vested on April 1, 2026, and that his beneficial ownership has been adjusted for a 1‑for‑10 reverse stock split effective April 6, 2026. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS, INC director Bill Carpou reported new equity awards in the form of Class A Common Stock. On February 25, 2026 and March 30, 2026, he received stock awards of 14,805 and 5,000 shares, respectively, at $0.00 per share as grant/award acquisitions. Footnotes state these awards relate to Restricted Stock Units granted on February 25, 2026 that vested on April 1, 2026.
Following these awards, Carpou directly owns 53,622 shares of Class A Common Stock. He also holds fully vested options to buy 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and options for 2,000 shares at $41.80 per share expiring on August 10, 2030. A footnote notes his beneficial ownership share count was adjusted for a 1-for-10 reverse stock split effected on April 6, 2026.
MOBIX Labs, Inc. director and CEO Philip Sansone reported an open-market sale of 9,541 shares of Class A Common Stock. The shares were sold at a weighted average price of $2.3544 per share to cover tax liabilities from restricted stock units that vested on April 30, 2026, under an irrevocable sell-to-cover election and not as discretionary trades.
After these transactions, Sansone directly holds 175,431 shares of Class A Common Stock. The company effected a 1-to-10 reverse stock split on April 6, 2026, which reduced his direct holdings.
Mobix Labs CEO Philip Sansone filed a Form 4 showing an automatic tax-related sale of shares. On February 2, 2026, Sansone sold 87,025 shares of Mobix Labs Class A common stock at a weighted-average price of $0.188 per share in a transaction coded as a sale.
According to the disclosure, the shares were sold solely to cover taxes arising from restricted stock units that vested on January 31, 2026, under a pre‑set “sell to cover” election, meaning the trades were not discretionary. After this transaction, Sansone directly beneficially owned 1,848,816 shares of Mobix Labs.